BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 22525674)

  • 1. pH-dependence of the specific binding of Cu(II) and Zn(II) ions to the amyloid-β peptide.
    Ghalebani L; Wahlström A; Danielsson J; Wärmländer SK; Gräslund A
    Biochem Biophys Res Commun; 2012 May; 421(3):554-60. PubMed ID: 22525674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
    Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
    J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-beta peptide.
    Nair NG; Perry G; Smith MA; Reddy VP
    J Alzheimers Dis; 2010; 20(1):57-66. PubMed ID: 20164601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the coordination of Cu(II) by the amyloid-B 16 peptide from Fourier transform IR spectroscopy and isotopic labeling.
    El Khoury Y; Dorlet P; Faller P; Hellwig P
    J Phys Chem B; 2011 Dec; 115(49):14812-21. PubMed ID: 22026330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-Dependent Cu(II) coordination to amyloid-β peptide: impact of sequence alterations, including the H6R and D7N familial mutations.
    Alies B; Eury H; Bijani C; Rechignat L; Faller P; Hureau C
    Inorg Chem; 2011 Nov; 50(21):11192-201. PubMed ID: 21980910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc-mediated modulation of the configuration and activity of complexes between copper and amyloid-β peptides.
    Liu L; Xia N
    Biochem Biophys Res Commun; 2012 Jan; 417(1):153-6. PubMed ID: 22138653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR metabolomic investigation of astrocytes interacted with Aβ₄₂ or its complexes with either copper(II) or zinc(II).
    Rocchi A; Valensin D; Aldinucci C; Giani G; Barbucci R; Gaggelli E; Kozlowski H; Valensin G
    J Inorg Biochem; 2012 Dec; 117():326-33. PubMed ID: 23062696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-dependent kinetics of copper ions binding to amyloid-β peptide.
    Bin Y; Chen S; Xiang J
    J Inorg Biochem; 2013 Feb; 119():21-7. PubMed ID: 23174653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
    Faller P; Hureau C
    Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes.
    Maiti NC; Jiang D; Wain AJ; Patel S; Dinh KL; Zhou F
    J Phys Chem B; 2008 Jul; 112(28):8406-11. PubMed ID: 18570397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper and zinc binding properties of the N-terminal histidine-rich sequence of Haemophilus ducreyi Cu,Zn superoxide dismutase.
    Paksi Z; Jancsó A; Pacello F; Nagy N; Battistoni A; Gajda T
    J Inorg Biochem; 2008 Sep; 102(9):1700-10. PubMed ID: 18565588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.
    Mekmouche Y; Coppel Y; Hochgräfe K; Guilloreau L; Talmard C; Mazarguil H; Faller P
    Chembiochem; 2005 Sep; 6(9):1663-71. PubMed ID: 16078307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
    Furlan S; Hureau C; Faller P; La Penna G
    J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.
    Lakatos A; Gyurcsik B; Nagy NV; Csendes Z; Wéber E; Fülöp L; Kiss T
    Dalton Trans; 2012 Feb; 41(6):1713-26. PubMed ID: 22159144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid beta-peptide.
    Suzuki K; Miura T; Takeuchi H
    Biochem Biophys Res Commun; 2001 Jul; 285(4):991-6. PubMed ID: 11467850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the possible roles of N-terminal His-rich domains of Cu,Zn SODs of some Gram-negative bacteria.
    Arus D; Jancsó A; Szunyogh D; Matyuska F; Nagy NV; Hoffmann E; Körtvélyesi T; Gajda T
    J Inorg Biochem; 2012 Jan; 106(1):10-8. PubMed ID: 22105012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.